Medicare Enrolled
Dr. Matthew Atkinson, M.D.
General Acute Care Hospital · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Atkinson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atkinson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Atkinson
Dr. Matthew Atkinson is a general acute care hospital specialist in Cincinnati, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Atkinson performed 6,796 Medicare services across 698 unique beneficiaries.
Between the years covered by Open Payments, Dr. Atkinson received a total of $7,097 from 45 pharmaceutical and/or device companies across 546 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in general acute care hospital. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Atkinson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in OH
$7,097 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,796
Medicare services
Top 6% in OH for general acute care hospital
698
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~358 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
6,000 | $15 | $46 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
161 | $89 | $331 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
110 | $64 | $1,165 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
97 | $198 | $1,380 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
79 | $61 | $237 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
62 | $75 | $1,413 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $99 | $418 |
| Dilation of esophagus | 29 | $33 | $687 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $61 | $229 |
| Endoscopic ultrasound of esophagus, stomach, or upper small bowel An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope. |
25 | $168 | $1,367 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
25 | $47 | $219 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $110 | $530 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
20 | $75 | $904 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
18 | $171 | $1,062 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
16 | $64 | $294 |
| Endoscopic ultrasound-guided needle biopsy A procedure using an ultrasound-equipped endoscope to guide a needle for tissue sampling of the esophagus, stomach, or upper small bowel. |
15 | $193 | $898 |
| Radiologist review of bile and pancreatic duct imaging A radiologist reviews images obtained from a tube placed into the bile and pancreatic ducts using an endoscope. |
12 | $21 | $290 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $72 | $344 |
| Pancreatic or bile duct stent insertion A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open. |
11 | $329 | $1,693 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
88.8% high complexity
4.1% medium
7.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,097
Total received (2018-2024)
Avg $1,014/year across 7 years
Top 20% in OH for general acute care hospital
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
546
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,080 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,328
2023
$901
2022
$1,276
2021
$1,180
2020
$449
2019
$916
2018
$1,048
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$391
Takeda Pharmaceuticals U.S.A., Inc.
$176
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$157
Janssen Biotech, Inc.
$94
Madrigal Pharmaceuticals
$78
Gilead Sciences, Inc.
$75
Ipsen Biopharmaceuticals, Inc
$73
GENZYME CORPORATION
$64
Regeneron Healthcare Solutions, Inc.
$52
QOL Medical, LLC
$42
Celgene Corporation
$32
Phathom Pharmaceuticals, Inc.
$25
PFIZER INC.
$20
Organon Llc
$17
Celltrion USA Inc.
$16
Lilly USA, LLC
$15
Top 3 companies account for 54.6% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,203
AbbVie Inc.
$938
ABBVIE INC.
$888
AbbVie, Inc.
$613
Takeda Pharmaceuticals U.S.A., Inc.
$556
Nestle HealthCare Nutrition Inc.
$268
PFIZER INC.
$237
Gilead Sciences, Inc.
$235
Celgene Corporation
$233
Janssen Biotech, Inc.
$224
Regeneron Healthcare Solutions, Inc.
$183
UCB, Inc.
$132
QOL Medical, LLC
$131
GENZYME CORPORATION
$111
Ferring Pharmaceuticals Inc.
$103
Ironwood Pharmaceuticals, Inc
$98
Madrigal Pharmaceuticals
$78
Ipsen Biopharmaceuticals, Inc
$73
Shire North American Group Inc
$72
Braintree Laboratories, Inc.
$68
IRONWOOD PHARMACEUTICALS, INC
$60
Synergy Pharmaceuticals Inc
$56
Phathom Pharmaceuticals, Inc.
$52
Amgen Inc.
$49
Romark Laboratories, LC
$47
NESTLE HEALTHCARE NUTRITION INC.
$46
Allergan, Inc.
$43
Prometheus Laboratories Inc.
$38
Lilly USA, LLC
$28
Medtronic, Inc.
$24
Aries Pharmaceuticals, Inc.
$18
Organon Llc
$17
Daiichi Sankyo Inc.
$16
Celltrion USA Inc.
$16
Intercept Pharmaceuticals, Inc.
$15
VIVUS LLC
$15
Merck Sharp & Dohme Corporation
$14
Concordia Pharmaceuticals Inc.
$14
Fresenius Kabi USA, LLC
$14
Axonics, Inc.
$13
Organon LLC
$12
Alnylam Pharmaceuticals Inc.
$12
Evoke Pharma, Inc.
$12
EVOKE PHARMA, INC.
$12
Alfasigma USA, Inc.
$12
Top 3 companies account for 42.7% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AVSOLA · Alinia Tablets 500mg 30 count bottle · Amitiza · Axonics r-SNM System · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · Donnatal · ELEVIEW · ENDOFLIP · ENTYVIO · EOHILIA · Entyvio · GATTEX · GIMOTI · GIVLAARI · HUMIRA · Humira · IDACIO · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · MOVIPREP · Mavyret · Motegrity · OMVOH · PANCREAZE · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUTAB · Sucraid · TREMFYA · TRULANCE · Trulance · UCERIS · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
General acute care hospitals within 10 mi
5
Per 100K population
0.6
County median income
$70,816
Nearest hospital
UNIVERSITY OF CINCINNATI MEDICAL CENTER, LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Atkinson is a mixed practice specialist, with above-average Medicare volume (top 6% in OH), with low-engagement industry engagement in the top 20% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Atkinson experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Atkinson performed 6,000 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atkinson receive payments from pharmaceutical companies?
Yes. Dr. Atkinson received a total of $7,097 from 45 companies across 546 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atkinson's costs compare to other general acute care hospitals in Cincinnati?
Dr. Atkinson's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atkinson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
General Acute Care Hospitals in Cincinnati
Browse general acute care hospitals in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top General Acute Care Hospitals in OH
General acute care hospitals ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to General Acute Care Hospitals in OH
Which OH general acute care hospitals receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology